FDA Inspection 1241040 — Ungerer & Co
The FDA completed an inspection of Ungerer & Co on Jun 5, 2024 in Bethlehem, PA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bethlehem, PA (United States)